Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Oat breakfast study reveals what your body keeps and flushes

NCT ID NCT07050680

Knowledge-focused Sponsor: University of Aberdeen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how healthy people absorb good nutrients and natural toxins from oats. Sixteen volunteers eat one oat breakfast and collect their urine for 48 hours. Researchers measure what comes out to understand both the health benefits and safety of oats. No treatment or long-term follow-up is involved.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 16 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Adult males and females (aged 18 - 65 years) who are healthy with a BMI in the normal to overweight range (18.5-29.9) Exclusion Criteria: * Anyone who currently suffers from gastrointestinal or metabolic diseases, liver disease or kidney disease * Anyone who currently has an eating disorder (anorexia, bulimia, binge eating, night eating syndrome) * Anyone who is taking prescribed medication related to gastrointestinal, metabolic, liver or kidney disease * Anyone who has taken antibiotics in the past 3 months * Anyone who is allergic or intolerant to oat foods * Anyone who is currently pregnant or breastfeeding * Anyone who is currently taking vitamin or mineral supplements (unless they agree to discontinue supplementation 2 weeks before the study) * Anyone currently participating in another research study * Anyone who is unable to fluently speak, read and understand English * Anyone who is unable to give written informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mycotoxin biomonitoring are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Mycotoxin biomonitoring

Contacts and locations

Locations

  • Rowett Institute, University of Aberdeen

    Aberdeen, AB25 2ZD, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.